NCT06766643View on ClinicalTrials.gov

Stereotactic Radiosurgery Versus Radiofrequency Ablation for Primary Liver Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

January 31, 2025

Primary Completion Date

January 31, 2025

Study Completion Date

December 31, 2026

Conditions
Primary Liver Cancer
Interventions
PROCEDURE

Stereotactic Body Radiation Therapy (SBRT)

Stereotactic radiosurgery for liver lesions: with a total dose of 40\~50Gy/3\~5fraction;

PROCEDURE

Radiofrequency ablation therapy

Radiofrequency ablation therapy:1 complete radiofrequency ablation of liver lesions for liver lesions

Trial Locations (1)

300060

RECRUITING

Department of Hepatobiliary Oncology and Radiation Oncology,Tianjin Medical University Cancer Institute & Hospital,Key Laboratory of Cancer Prevention and Therapy,National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin

All Listed Sponsors
lead

Tianjin Medical University Cancer Institute and Hospital

OTHER